Barreiro P - Search Results

1

Directly acting antivirals against hepatitis C virus.

Soriano V, Vispo E, Poveda E, Labarga P, Martin-Carbonero L, Fernandez-Montero JV, Barreiro P. Soriano V, et al. Among authors: barreiro p. J Antimicrob Chemother. 2011 Aug;66(8):1673-86. doi: 10.1093/jac/dkr215. Epub 2011 Jun 7. J Antimicrob Chemother. 2011. PMID: 21652618 Review.

2

Discontinuation of secondary prophylaxis for opportunistic infections in HIV-infected patients receiving highly active antiretroviral therapy.

Soriano V, Dona C, Rodríguez-Rosado R, Barreiro P, González-Lahoz J. Soriano V, et al. Among authors: barreiro p. AIDS. 2000 Mar 10;14(4):383-6. doi: 10.1097/00002030-200003100-00011. AIDS. 2000. PMID: 10770540

3

Risks and benefits of replacing protease inhibitors by nevirapine in HIV-infected subjects under long-term successful triple combination therapy.

Barreiro P, Soriano V, Blanco F, Casimiro C, de la Cruz JJ, González-Lahoz J. Barreiro P, et al. AIDS. 2000 May 5;14(7):807-12. doi: 10.1097/00002030-200005050-00006. AIDS. 2000. PMID: 10839588 Clinical Trial.

4

Prevention of nevirapine-associated exanthema using slow dose escalation and/or corticosteroids.

Barreiro P, Soriano V, Casas E, Estrada V, Téllez MJ, Hoetelmans R, de Requena DG, Jimenéz-Nácher I, González-Lahoz J. Barreiro P, et al. AIDS. 2000 Sep 29;14(14):2153-7. doi: 10.1097/00002030-200009290-00012. AIDS. 2000. PMID: 11061657 Clinical Trial.

5

[Toxicity associated to efavirenz in HIV-infected persons enrolled in an expanded access program].

Dona C, Soriano V, Barreiro P, Jiménez-Náchera I, González-Lahoz J. Dona C, et al. Among authors: barreiro p. Med Clin (Barc). 2000 Sep 23;115(9):337-8. doi: 10.1016/s0025-7753(00)71549-1. Med Clin (Barc). 2000. PMID: 11093894 Spanish.

6

Induction-maintenance (5 --> 3 drugs) in HIV-infected patients with high viral load.

Soriano V, Barreiro P, Gonzalez-Lahoz J. Soriano V, et al. Among authors: barreiro p. AIDS Patient Care STDS. 2000 Nov;14(11):573-4. doi: 10.1089/10872910050193734. AIDS Patient Care STDS. 2000. PMID: 11155897 No abstract available.

7

Tolerability of abacavir in the clinical setting.

Martín-Carbonero L, Barreiro P, Soriano V, González-Lahoz J. Martín-Carbonero L, et al. Among authors: barreiro p. Clin Microbiol Infect. 2000 Nov;6(11):621-2. doi: 10.1046/j.1469-0691.2000.00162.x. Clin Microbiol Infect. 2000. PMID: 11168068 Free article. No abstract available.

8

Is there a role for indinavir twice-daily in clinical practice?

Barreiro P, Soriano V, Cabello N, González-Lahoz J. Barreiro P, et al. Clin Microbiol Infect. 2000 Mar;6(3):152-4. doi: 10.1046/j.1469-0691.2000.00034-3.x. Clin Microbiol Infect. 2000. PMID: 11168093 Free article. No abstract available.

9

[Opportunistic episodes in patients infected with the human immunodeficiency virus during the first 6 months of HAART].

González-Castillo J, Blanco F, Soriano V, Barreiro P, Concepción Bravo M, Jiménez-Nácher I, González-Lahoz J. González-Castillo J, et al. Among authors: barreiro p. Med Clin (Barc). 2001 Jun 23;117(3):81-4. doi: 10.1016/s0025-7753(01)72024-6. Med Clin (Barc). 2001. PMID: 11459574 Spanish.

10

Different degree of immune recovery using antiretroviral regimens with protease inhibitors or non-nucleosides.

Barreiro P, Soriano V, Casas E, González-Lahoz J. Barreiro P, et al. AIDS. 2002 Jan 25;16(2):245-9. doi: 10.1097/00002030-200201250-00014. AIDS. 2002. PMID: 11807309

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

459 results

Search Page

Filters